Showing 2,101 - 2,120 results of 44,251 for search '(( 5 ((nn decrease) OR (mean decrease)) ) OR ( 50 ((ng decrease) OR (a decrease)) ))', query time: 1.02s Refine Results
  1. 2101
  2. 2102
  3. 2103
  4. 2104

    OCA alone markedly decreases and combined with Gemcitabine or Cisplatin abrogates growth of iCCA xenografts. by S. Di Matteo (6260417)

    Published 2019
    “…However, co-treatment of OCA with Gemcitabine or Cisplatin resulted in a tumor volume significantly lower compared to Gemcitabine or Cisplatin alone (p < 0.05). Means ± SE of N = 5 for each group. * p < 0.05 vs controls, <sup>&</sup> p < 0.05 vs OCA, <sup>¤</sup> p < 0.05 vs Cisplatin alone, <sup>§</sup> p < 0.05 vs Gemcitabine alone. …”
  5. 2105
  6. 2106
  7. 2107
  8. 2108
  9. 2109
  10. 2110
  11. 2111
  12. 2112
  13. 2113
  14. 2114

    A: MET+5-FU treatment significantly increased the percentage of annexin V+ apoptotic cells as compared with 5-FU alone treatment (Early apoptosis rate: 3.50 ± 0.44 % vs 2.33 ± 0.38... by Yanfei Zhang (488656)

    Published 2013
    “…<p>*, p<0.05 and ***, p<0.001 for comparisons between the MET+5-FU group and the 5-FU alone group. B: The proportion of CD133 + cells was significantly decreased by the MET+5-FU treatment as compared with 5-FU alone treatment (15.13± 3.43 vs 21.30 ± 1.40; p=0.027). …”
  15. 2115
  16. 2116
  17. 2117
  18. 2118
  19. 2119
  20. 2120

    mGluR5 binding potential (BP<sub>ND</sub>) decreased in epilepsy models according to time periods after status epilepticus. by Hongyoon Choi (541919)

    Published 2014
    “…In subacute period, mGluR5 BP<sub>ND</sub> recovered in caudate-putamen, while decreased yet in hippocampus and amygdala, and in chronic period, there was no significant difference in BP<sub>ND</sub> between model rats and controls using VOI-based analysis. …”